Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Toronto

$31,000.00

Molecular regulation of glucose metabolism by orphan nuclear receptors

EF 2012-13

Résumé
The objective of this research program is to identify novel mechanisms by which orphan nuclear receptors control the activation and repression of genes involved in glucose metabolism. Activation of the liver X receptor alpha (LXRa) inhibits the expression of key genes involved in glucose metabolism including the rate-limiting enzyme in glucose synthesis, phosphoenolpyruvate carboxykinase (PEPCK). Preliminary data from this lab have also demonstrated that the liver X receptor beta (LXRb) is required for the glucocorticoid (GC)-mediated upregulation of PEPCK, suggesting that an important and currently unrecognized molecular interplay is occurring between the nuclear receptors glucocorticoid receptor and the LXRs. The first objective will be to determine the molecular mechanism of LXRa-mediated transrepression of genes involved in glucose metabolism. The second objective will be to identify novel mechanisms of interaction between GC and the orphan nuclear receptor LXRb in the control of glucose metabolism. Using sophisticated technology for genomic and proteomic analysis, we will determine whether direct regulation of GC-responsive genes is occurring with LXRs or whether the effect is secondary to altered regulation of another intermediate protein. We will determine whether or not these nuclear receptors are associated with these active promoters and where they are located in the promoter context. This research program has the important function of identifying completely novel molecular mechanisms for GC signaling and glucose regulation with a high probability for uncovering how members of this receptor superfamily converge at the molecular level on metabolic signaling pathways. The benefit to Canada will come not only in the form of an enhanced research environment for trainees and increased visibility in the quality of research in Canada but also in the discovery of new molecular components regulating the critically important process of glucose metabolism.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
356873-2008
Name nom
Cummins, Carolyn
Department département
Pharmacy, Leslie Dan Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2008
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Partie
5
Nb partie
5
Application title
Molecular regulation of glucose metabolism by orphan nuclear receptors
Keyword
NSERC
Application summary
The objective of this research program is to identify novel mechanisms by which orphan nuclear receptors control the activation and repression of genes involved in glucose metabolism. Activation of the liver X receptor alpha (LXRa) inhibits the expression of key genes involved in glucose metabolism including the rate-limiting enzyme in glucose synthesis, phosphoenolpyruvate carboxykinase (PEPCK). Preliminary data from this lab have also demonstrated that the liver X receptor beta (LXRb) is required for the glucocorticoid (GC)-mediated upregulation of PEPCK, suggesting that an important and currently unrecognized molecular interplay is occurring between the nuclear receptors glucocorticoid receptor and the LXRs. The first objective will be to determine the molecular mechanism of LXRa-mediated transrepression of genes involved in glucose metabolism. The second objective will be to identify novel mechanisms of interaction between GC and the orphan nuclear receptor LXRb in the control of glucose metabolism. Using sophisticated technology for genomic and proteomic analysis, we will determine whether direct regulation of GC-responsive genes is occurring with LXRs or whether the effect is secondary to altered regulation of another intermediate protein. We will determine whether or not these nuclear receptors are associated with these active promoters and where they are located in the promoter context. This research program has the important function of identifying completely novel molecular mechanisms for GC signaling and glucose regulation with a high probability for uncovering how members of this receptor superfamily converge at the molecular level on metabolic signaling pathways. The benefit to Canada will come not only in the form of an enhanced research environment for trainees and increased visibility in the quality of research in Canada but also in the discovery of new molecular components regulating the critically important process of glucose metabolism.